Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

SELLAS Life Sciences Group, Inc. Director's Dealing 2014

Jul 30, 2014

33651_dirs_2014-07-29_584d1c88-c6a7-4adb-9491-219d38519de8.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Galena Biopharma, Inc. (GALE)
CIK: 0001390478
Period of Report: 2014-07-28

Reporting Person: Kivinski Margaret (VP and General Counsel)

More from SELLAS Life Sciences Group, Inc.

Regulatory Filings 2026
May 12
Interim / Quarterly Report 2026
May 12
Major Shareholding Notification 2026
Mar 27
Regulatory Filings 2026
Mar 20
Major Shareholding Notification 2026
Jan 30
Director's Dealing 2026
Jan 9
Director's Dealing 2026
Jan 9
Director's Dealing 2026
Jan 9
Director's Dealing 2026
Jan 9
Director's Dealing 2026
Jan 9
View all filings →